MACKENZIE ALEXANDER R 4
4 · PFIZER INC · Filed Feb 28, 2020
Insider Transaction Report
Form 4
PFIZER INCPFE
MACKENZIE ALEXANDER R
Executive Vice President
Transactions
- Award
Common Stock
2020-02-26+21,202→ 101,323 total - Award
Common Stock
2020-02-26+17,087→ 118,410 total - Tax Payment
Common Stock
2020-02-26$34.72/sh−7,984$277,204→ 110,426 total - Tax Payment
Common Stock
2020-02-26$34.72/sh−8,104$281,371→ 102,322 total - Award
Stock Appreciation Rights
2020-02-27+102,221→ 102,221 totalExercise: $34.10From: 2025-02-27Exp: 2025-02-27→ Common Stock (102,221 underlying) - Award
Stock Appreciation Rights
2020-02-27+87,581→ 87,581 totalExercise: $34.10From: 2027-02-27Exp: 2027-02-27→ Common Stock (87,581 underlying)
Holdings
- 9,702(indirect: By Rule 16b-3 Plan)
Common Stock
Footnotes (4)
- [F1]The reported transaction constitutes the earn-out of Performance Share Awards (including dividend equivalents thereon).
- [F2]The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the earn-out of Performance Share Awards (including dividend equivalents thereon).
- [F3]The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.
- [F4]The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant.